FEBS MPST 2013

Name

Address & e-mail

Scientific Field

Renato Iozzo

Department of Pathology
Anatomy & Cell Biology
Thomas Jefferson University, Philadelphia, USA

Proteoglycan,
Cancer Biology,
Tumor Angiogenesis

Vincent Hascall

Hyaluronan in inflammatory
pathologies

Dick Heinegård

Department of Experimental Medical Sciences
Lund University
Lund, Sweden

Cell-matrix interactions,
cell surface receptors,
extracellular matrix composition

Nikos Karamanos

Biochemistry, Biochemical Analysis
& Matrix Pathobiology Research Group,
Laboratory of Biochemistry,
Department of Chemistry,
University of Patras, Greece

Matrix Molecular Targets in Cancer,
Proteoglycans,
Metalloproteinases,
ER crosstalk signaling

John Couchman

Department of Biomedical Sciences,
University of Copenhagen, Denmark

Syndeacns in cell adhesion,
receptors and signaling

Israel Vlodavski

Cancer and Vascular and Biology Research Center,
The Bruce Rappaport Faculty of Medicine,
Technion, Haifa 31096, Israel

Tumor-microenvironment;
Heparan sulfate;
Heparanase in Cancer inflammation
& diabetic nephropathy

Jan-Olof Winberg

Department of Medical Biology,
Faculty of Medicine,
University of Tromsø, Norway

Matrix MMPs, Protein complexes,
Enzyme kinetics and inhibition kinetics

Liliana Schaefer

Pharmazentrum Frankfurt,
Institut für Allgemeine Pharmakologie und Toxikologie,
Frankfurt am Main, Germany

SLRPs, signaling,
inflammation, fibrosis, kidney

Donald Gullberg

Department of Biomedicine,
University of Bergen, Norway

Integrins – tumor stroma
interactions, fibroblasts

Achilleas Theocharis

Laboratory of Biochemistry,
Department of Chemistry,
University of Patras, Greece

Proteoglycans (serglycin) in
multiple myeloma and cancer progression

Paraskevi Heldin

Ludwig Institute for Cancer Research,
Uppsala University,
Biomedical Center, Sweden

Importance of microenvironment
in tumor progression,
Hyaluronan and HAS signaling,
proteasome implication

Jeffrey D. Esko

Department of Cellular and Molecular Medicine,
University of California,
San Diego, La Jolla, USA

Proteoglycans, heparan sulfate,
lysosomal storage, lipoprotein metabolism

Alberto Passi

Dipartimento di Scienze Biomediche Sperimentali e Cliniche,
Universita degli Studi dell'Insubria,
Varese, Italy

Metabolic control of proteoglycans
and pathobiology

Carl-Henrik Heldin

Ludwig Institute for Cancer Research,
Uppsala University,
Biomedical Center, Sweden

Signal transduction
via PDGF receptors
and TGFbeta receptors

Dragana Nikitovic

Department of Anatomy,
School of Medicine,
University of Crete, Heraklion, Greece

Tumor biology and ECM

Lena Kjellen

Department of Medical Biochemistry and Microbiology,
Uppsala University, BMC, Sweden

Heparin sulfate biosynthesis;
Heparan sulfate
and embryonic development

Kazuyuki Sugahara

Lab. of Proteoglycan signalling and therapeutics,
Faculty of Advanced Life Sciences,
University of Hokkaido, Japan

Functions of glycosaminoglycans
and proteoglycans

Dimitris Kletsas

Laboratory of Cell proliferation & Ageing,
Institute of Biology,
National Centre for Scientific Research "Demokritos",
Athens, Greece

Cellular senescence and age-related pathologies,
extracellular matrix, growth factors,
signaling pathways, stress, wound healing,
cancer, biomaterials, stem cells
and cell replacement therapy

David Birk

Department of Molecular Pharmacology & Physiology,
University of South Florida,
Morsani College of Medicine,
Florida 33612

Regulation of tissue-specific matrix assembly;
Matrix macromolecule interations in regulation
of assembly; molecular basis of
connective tissue diseases

Jorge Filmus

Sunnybrook Research Institute,
Toronto, ON, Canada

Glypicans in development
and cancer

Veli-Matti Kähäri

Department of Dermatogy,
University of Turku, Finland

Proteinases, ECM,
skin cancer, wound repair

Thomas N. Wight

Hope Heart Matrix Biology Program
Benaroya Research Institute,
Seattle, University of Washington

Proteoglycans in the Control
of Inflammation in Cardiovascular
and Control of Cell Phenotype

Ralph Sanderson

Dept. of Pathology
Univ. Alabama at Birmingham,
Alabama, USA

Heparan sulfate/tumor microenvironment,
Heparanase signaling

Themis R. Kyriakides

Departments of Pathology
and Biomedical Engineering,
Yale University,
New Haven, USA

Extracellular matrix and
vascular biology

Peter Friedl

Microscopical Imaging of the Cell Department
of Cell Biology, NCMLS,
Radboud University Nijmegen Medical Centre,
The Netherlands &
Section Chief Molecular Imaging
The University of Texas
MD Anderson Cancer Center,
Houston, TX, USA

Intravital imaging of cancer invasion
and- evaluation of anti-invasion compounds

Alan J. Grodzinsky

MIT Center for Biomedical Engineering,
Departments of Biological, Electrical and
Mechanical Engineering,
MIT, Cambridge, USA

Protein-proteoglycan interactions
using advanced AFM techniques

Boris Turk

Head of Dept. Biochem.,
Mol. & Struct. Biol.,
J. Stefan Institute Jamova,
Ljubljana, Slovenia

Cysteine proteases, quantitative proteomics,
in-vivo imaging, in-vivo models,
protein-degrading enzymes
as key signaling molecules

Mauro Pavao

Program of Glycobiology,
Institute of Medical Biochemistry,
Federal University of Rio de Janeiro,
Brazil

Heparin nanoparticles for pharmacological targeting
in thrombosis, tumor invasion and metástasis

Martin Götte

Muenster University,
Medical CenterAlbert-Schweitzer-Campus,
Muenster, Germany

breast cancer, syndecans,
dermatan sulfate proteoglycans and
molecular mechanisms of angiogenesis.

François Maquart

Laboratoire Central de Biochimie,
Hôpital Robert Debré,
CHU de Reims,
Reims, France

Extracellular matrix, proteoglycans,
glycosaminoglycans in disease